IL1A and hepatocellular carcinoma: Some mechanistic studies using human hepatoma HepG2 cells found that IL-1 can inhibit cholesterol synthesis and decrease cholesterol and Apo-B secretion, and IL-6 can increase cholesterol synthesis but decrease even more cholesterol secretion (84, 85).